Apollo Hospitals Enterprise Limited has successfully concluded the acquisition of an additional 30.58% equity stake in its subsidiary, Apollo Health and Lifestyle Limited (AHLL). The transaction, previously approved by the Board and later cleared by the Competition Commission of India (CCI) on January 20, 2026, was finalized for a total consideration of Rs. 12,540.68 million. This strategic move boosts Apollo’s effective shareholding in AHLL to an overwhelming 99.42%.
Completion of Major Equity Transaction
Apollo Hospitals Enterprise Limited formally announced the completion of a significant transaction involving its subsidiary, Apollo Health and Lifestyle Limited (AHLL). This move follows earlier intimations made to the exchanges on September 12, 2025, and January 21, 2026.
Transaction Details and Consideration
The Board of Directors had approved the acquisition of 41,650,638 equity shares, which constituted a 30.58% equity stake. These shares were jointly held by the International Finance Corporation (Washington) (IFC) and IFC EAF Apollo Investment Company (IFC EAF). The total purchase consideration paid for this stake amounted to Rs. 12,540.68 million.
The transaction was contingent upon receiving necessary clearances, which were secured when the Competition Commission of India (CCI) granted its approval on January 20, 2026.
Resulting Shareholding Structure
With the successful closure of this acquisition announced on March 23, 2026, the effective shareholding of Apollo Hospitals Enterprise Limited in Apollo Health and Lifestyle Limited has substantially increased to 99.42%.
Source: BSE
